Precision medicine player joins Biden Cancer Initiative aiming to improve clinical trials access

Precision medicine and clinical trial matching specialist Massive Bio is partnering with the initiative. Massive Bio’s precision medicine approach is based on a genetic understanding of the patient, allowing doctors to better select treatments most likely to help those patients.

Powered by WPeMatico